Plaza-Díaz, J.; Solis-Urra, P.; Aragón-Vela, J.; Rodríguez-Rodríguez, F.; Olivares-Arancibia, J.; Álvarez-Mercado, A.I.
Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021, 9, 145.
https://doi.org/10.3390/biomedicines9020145
AMA Style
Plaza-Díaz J, Solis-Urra P, Aragón-Vela J, Rodríguez-Rodríguez F, Olivares-Arancibia J, Álvarez-Mercado AI.
Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines. 2021; 9(2):145.
https://doi.org/10.3390/biomedicines9020145
Chicago/Turabian Style
Plaza-Díaz, Julio, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, and Ana I. Álvarez-Mercado.
2021. "Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis" Biomedicines 9, no. 2: 145.
https://doi.org/10.3390/biomedicines9020145
APA Style
Plaza-Díaz, J., Solis-Urra, P., Aragón-Vela, J., Rodríguez-Rodríguez, F., Olivares-Arancibia, J., & Álvarez-Mercado, A. I.
(2021). Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines, 9(2), 145.
https://doi.org/10.3390/biomedicines9020145